TIP49 regulates beta-catenin-mediated neoplastic transformation and T-cell factor target gene induction via effects

Ying Feng1, Nana Lee, Eric R Fearon

  • 1Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.

Cancer Research
|December 26, 2003
PubMed

Insights

TIP49 protein acts as a cofactor in beta-catenin/T-cell factor (TCF) gene regulation. Inhibiting TIP49 function blocks cancer cell growth and TCF-dependent gene expression, suggesting a role in chromatin remodeling.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Epigenetics

Background:

  • Beta-catenin is crucial for Wnt signaling and T-cell factor (TCF)-mediated transcription.
  • Dysregulated beta-catenin is implicated in numerous cancers, driving neoplastic transformation.
  • Factors cooperating with beta-catenin in gene transcription remain incompletely understood.

Purpose of the Study:

  • To investigate the role of TIP49 as a cofactor in beta-catenin/TCF-mediated transcription.
  • To determine the impact of TIP49 on neoplastic transformation and TCF-dependent gene expression.
  • To elucidate the mechanism by which TIP49 influences gene regulation, potentially involving chromatin remodeling.

Main Methods:

  • Utilized an ATPase-deficient TIP49 mutant (TIP49D302N) to inhibit beta-catenin function.
  • Employed small interfering RNA (siRNA) to reduce endogenous TIP49 levels.
  • Performed chromatin immunoprecipitation (ChIP) assays to assess protein-DNA interactions and histone acetylation.
  • Analyzed the expression of TCF-dependent genes, including ITF-2.

Main Results:

  • TIP49 inhibition, via TIP49D302N or siRNA, significantly reduced beta-catenin-mediated neoplastic transformation and anchorage-independent growth of cancer cells.
  • TIP49 inhibition suppressed the activation of beta-catenin/TCF-dependent genes.
  • TIP49 was found in complexes with chromatin remodeling factors and co-immunoprecipitated with TIP60 and TRRAP.
  • TIP49, TIP60, and TRRAP interact with regulatory regions of TCF-dependent genes like ITF-2.
  • TIP49 inhibition led to decreased histone acetylation at TCF-binding sites in the ITF-2 promoter.

Conclusions:

  • TIP49 functions as a critical cofactor in beta-catenin/TCF gene regulation in both normal and cancer cells.
  • TIP49 likely exerts its function through involvement in chromatin remodeling processes.
  • Targeting TIP49 may represent a therapeutic strategy for cancers with aberrant Wnt/beta-catenin signaling.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...